Klinische Studie

Prospective, multicenter study to evaluate the Hepatocellular Carcinoma Immune Score as prognosticator for overall and disease-free survival of patients after resection of Hepatocellular Carcinoma.(HCCIS as prognosticator for overall and disease-free survival of patients after resection of HCC)To establish the Hepatocellular Immune Score (HCCIS) as a new tool for risk stratification of patients after resection of hepatocellular carcinoma that can be widely used in the clinical practice.
EUDRACT-
NCTNCT02718235
DRKS-
Krankheitsentität(en) Leber
StudientypBeobachtungsstudie
Wesentliche EinschlusskriterienHCC Resektion >18 Jahre
Wesentliche AusschlusskriterienSchwangerschaft LTX
StatusStudie beendet
Ansprechpartner & KontaktUniversitätsklinikum RegensburgChirurgieStudienzentrale0941 9446736cotrialassociates(at)ukr.de
zurück